Advances in Surgical Pathology: Lung Cancer.
Advances in Surgical Pathology: Lung Cancer
Author(s):
Quantity:
Publication Date: 2010
Availability: In Stock
Format:
ISBN/ISSN: 9781605475912

Description

Advances in Surgical Pathology: Lung Cancer, a volume in the Advances in Surgical Pathology series, features chapters on current and impending changes in the field of lung cancer that directly affect pathologists. This includes the 2004 updates of the WHO Classification of Tumors of the Lung; the ongoing new classification of neuroendocrine carcinomas of the lung by the International Association for the Study of Lung Cancer; the ongoing revision of the pathologic and clinical staging of lung cancer by the AJCC; molecular diagnostics in the diagnosis of lung cancer; the role of the pathologist in the new molecular targeted therapies for lung cancer; and the new use of image-guided, multimodality theranostics for the diagnosis and treatment of lung cancer. Other current topics discussed include new understanding of the premalignant and preinvasive lesions and the controversies and revisions of the diagnosis of bronchioloalveolar carcinoma.

Rights Link

Go to Cart
--Highlights recent advances and emerging technologies in the pathology of lung cancer and their relationship to clinical care
--Special focus on the convergence of pathology and radiology
--Emphasizes molecular diagnostics/testing as well as targeted therapies
--Full-color illustrations and full solution site
Timothy Allen MD, JD
Professor and Chairman, Department of Pathology, The University of Texas Health Science Center at Tyler, Tyler, TX

Philip T. Cagle MD
Professor of Pathology, Department of Pathology, Weill Medical College of Cornell University, New York, NY; Director, Pulmonary Pathology, Department of Pathology, The Methodist Hospital, Houston, TX


Edition: NULL
ISBN/ISSN: 9781605475912
Product Format: Hardbound
Trim Size: 7 x 10
Pages: 304
Pub Date: 2010
Weight: 1.8

Section 1. Overview (include immunohistochemistry)

  • Chapter 1: Introduction
  • Chapter 2: Overview of Lung Cancer
  • Section 2. Histopathology

  • Chapter 3: Adenocarcinoma
  • Chapter 4: Bronchioloalveolar Carcinomas
  • Chapter 5: Changing Concepts of Bronchioloalveolar Carcinoma and Adenocarcinoma
  • Chapter 6: Squamous Cell Carcinoma
  • Chapter 7: Adenosquamous Carcinoma
  • Chapter 8: Large Cell Carcinoma
  • Chapter 9: Small Cell Carcinoma
  • Chapter 10: Carcinoid Tumor
  • Chapter 11: Atypical Carcinoid
  • Chapter 12: Update on Classification of Neuroendocrine Carcinomas
  • Chapter 13: Sarcomatoid (Sarcomatous) Carcinoma
  • Chapter 14: Giant Cell Carcinoma
  • Chapter 15: Pulmonary Blastoma
  • Chapter 16: Salivary Gland-like Carcinomas
  • Chapter 17: Metastatic Carcinoma
  • Section 3. Imaging

  • Chapter 18: Correlation of Imaging with Histopathology of Lung Cancer
  • Chapter 19: New Imaging Techniques for the Diagnosis and Staging of Lung Cancer
  • Chapter 20: Multimodality Theranostics and Molecular Radiology in the Diagnosis and Treatment of Lung Cancer
  • Section 4. Molecular Pathology

  • Chapter 21: Molecular Diagnostics of Lung Cancer
  • Chapter 22: Molecular Targeted Therapy of Lung Cancer
  • Chapter 23: Molecular Prognostic Markers of Lung Cancer
  • Section 5. Staging

  • Chapter 24: Problems in the Staging of Lung Cancer
  • Chapter 25: New Staging System for Lung Cancer
  • Section 6. Preneoplastic and Preinvasive Lesions

  • Chapter 26: Squamous cell carcinoma precursors
  • Chapter 27: Atypical adenomatous hyperplasia
  • Chapter 28: Diffuse idiopathic neuroendocrine hyperplasia
  • Chapter 29: Other Precursors of Pulmonary Carcinomas
PROD-ECOMM1 rv0oymleqlsfodo31pbawf22 54.90.19.30